13 studies found for:    EDTMP
Show Display Options
Rank Status Study
1 Completed Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Conditions: Breast Cancer;   Bone Metastases
Interventions: Drug: 153 Sm-EDTMP;   Behavioral: Questionnaire;   Procedure: Stem Cell Transplant
2 Recruiting Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: Sm-EDTMP;   Other: Autologous Stem Cell Infusion;   Radiation: External Beam Radiotherapy
3 Completed
Has Results
153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Samarium Sm 153 lexidronam pentasodium;   Biological: Sargramostim;   Biological: Recombinant vaccinia-TRICOM vaccine;   Biological: Recombinant fowlpox-TRICOM vaccine
4 Completed Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Docetaxel
5 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Pain
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Radiation: Sm 153 lexidronam
6 Completed Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Other: immunologic technique;   Radiation: samarium Sm 153 lexidronam pentasodium
7 Completed Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: sargramostim;   Drug: melphalan;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
8 Unknown  Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer
Condition: Prostatic Neoplasms
Intervention: Drug: Samarium Sm-153 lexidronam + Docetaxel
9 Completed Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma
Condition: Sarcoma
Interventions: Biological: filgrastim;   Drug: ifosfamide;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation;   Radiation: samarium Sm 153 lexidronam pentasodium
10 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy (3D-CRT);   Radiation: intensity-modulated radiation therapy (IMRT);   Radiation: samarium Sm 153 lexidronam pentasodium
11 Completed Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Radiation: samarium Sm 153 lexidronam pentasodium
12 Unknown  Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CAF regimen;   Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: fluorouracil;   Drug: ifosfamide;   Drug: melphalan;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: samarium Sm 153 lexidronam pentasodium
13 Completed
Has Results
Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Samarium-153;   Drug: Total Androgen Suppression (TAS) with Bicalutamide;   Drug: Total androgen suppression (TAS) with Goserelin Acetate;   Device: Radiation Therapy

Indicates status has not been verified in more than two years